KLF5 Inhibition Overcomes Oxaliplatin Resistance in Patient-Derived Colorectal Cancer Organoids by Restoring Apoptotic Response

By
Justin.choi
-
0
157
Researchers constructed colorectal cancer PDOs and selected the Kruppel-like factor 5 (KLF5) inhibitor ML264 as the research object based on the results of an in vitro drug screening assay.
[Cell Death & Disease]

Sorry, but the selected Zotpress account can't be found.

Full Article